Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 71

Sort by

Sort Order Select

Journal Articles

Generation of Fanconi Anemia iPSC Clones By Addition of a Small Molecule Inhibitor of p53 during Reprogramming

Husam Qanash, MSc, Kaari Linask, Jeannette Beers, Jizhong Zou, Andre Larochelle, MD PhD

Blood (2018) 132 (Supplement 1): 3857.

https://doi.org/10.1182/blood-2018-99-116896

Published: 2018

Journal Articles

Congenital X-Linked Myelodysplasia with Tetraploidy Is Associated with De Novo Germline C-Terminal Mutation of SEPT6, a Septin Filament Protein

Raffaele Renella, MD PhD, Katelyn Gagne, BS, Ellen Beauchamp, BA, Thorsten Schlaeger, PhD, Inga Hofmann, MD, Akiko Shimamura, MD PhD, Jonathan Fogel, BSc, Suneet Agarwal, MDPhD, Benjamin L. Ebert, MDPhD, Kyriacos Markianos, Timothy A. Springer, PhD, Mark D. Fleming, MD DPhil, David A. Williams, MD

Blood (2018) 132 (Supplement 1): 644.

https://doi.org/10.1182/blood-2018-99-114682

Published: 2018

Journal Articles

Human Pluripotent Stem Cell-Derived Blood Cells for Therapies

Dan S Kaufman, MD PhD

Blood (2018) 132 (Supplement 1): SCI-14.

https://doi.org/10.1182/blood-2018-99-109424

Published: 2018

Journal Articles

Platelet-Targeted Gene Therapy of Hemophilia a Using Hematopoietic Stem Cells Derived from Genome-Edited Induced Pluripotent Stem Cells

Dawei Wang, Guowei Zhang, Junjie Gu, Xiaohu Shao, Xiaohong Pan, Shuxian Yao, Ying Jin, Qizhen Shi, MD PhD, Zhu Chen, PhD, Sai-Juan Chen, PhD

Blood (2017) 130 (Supplement 1): 2063.

https://doi.org/10.1182/blood.V130.Suppl_1.2063.2063

Published: 2017

Journal Articles

The Activated TGFβ Pathway in Shwachman Diamond Syndrome Impairs Hematopoiesis and Is Down-Regulated By Deletion of 7q

Melisa Ruiz-Gutierrez, MD PhD, Cailin Joyce, PhD, Ozge Vargel Bolukbasi, PhD, Andriana Kotini, PhD, Gabriela Alexe, Jennifer Whangbo, MD PhD, David Russell, MDPhD, Kimberly Stegmaier, MD, Carl D. Novina, MD PhD, Eirini P. Papapetrou, MD PhD, Akiko Shimamura, MD

Blood (2017) 130 (Supplement 1): 875.

https://doi.org/10.1182/blood.V130.Suppl_1.875.875

Published: 2017

Journal Articles

Efficient Ex Vivo Expansion of Human Umbilical Cord Blood-Derived Small CD133 + lin - CD45 - Stem Cells Expressing Pluripotency Markers in Presence of Histone Deacethylase Inhibitors—As a New Challenging Strategy to Obtain Multipotent Cells for Regenerative Medicine

Janina Ratajczak, MD PhD DSci, Malwina Suszynska, PhD, Kamila Bujko, MS, Donald M Miller, MD PhD, Magdalena Kucia, PhD DSci, Mariusz Z Ratajczak, MD PhD DSc

Blood (2017) 130 (Supplement 1): 3761.

https://doi.org/10.1182/blood.V130.Suppl_1.3761.3761

Published: 2017

Journal Articles

B Cell-Derived Induced Pluripotent Stem Cells Are Useful for Determining the Cellular Origin of Abnormal B Cells in Multiple Myeloma

Aki Yanagi, Fumihiko Kawamura, MS, Makoto Inaki, PhD, Atsushi Katafuchi, PhD, Yukari Yanai, MS, Yu Abe, MD, Naohiro Tsuyama, PhD, Misaki Sugai, BS, Mitsunori Higuchi, MD PhD, Satoshi Muto, MD PhD, Takumi Yamaura, MD, Hiroyuki Suzuki, MD PhD, Hideyoshi Noji, MD PhD, Shinichi Suzuki, MD PhD, Yoshida A Mitsuaki, PhD, Megumi Sasatani, PhD, Kenji Kamiya, MD PhD, Masafumi Onodera, MD PhD, Akira Sakai, MDPhD

Blood (2017) 130 (Supplement 1): 1808.

https://doi.org/10.1182/blood.V130.Suppl_1.1808.1808

Published: 2017

Journal Articles

Ips Technology Revealed the Genetic and Functional Diversity Present in a Secondary AML Patient

Kazuhisa Chonabayashi, MD PhD, Masahiro Kawahara, MD PhD, Akira Watanabe, PhD, Masahiro Nakamura, MD PhD, Masatoshi Nishizawa, MD, Akifumi Takaori-Kondo, MD PhD, Shinya Yamanaka, MD PhD, Yoshinori Yoshida, MD PhD

Blood (2016) 128 (22): 4312.

https://doi.org/10.1182/blood.V128.22.4312.4312

Published: 2016

Journal Articles

Generation of Induced Pluripotent Stem Cell-Derived Erythroblasts from a Patient with X-Linked Sideroblastic Anemia

Shunsuke Hatta, MD, PhD, Tohru Fujiwara, MD, PhD, Takako Yamamoto, Mayumi Kamata, MD, Yoshiko Tamai, Yukio Nakamura, MD, PhD, Shin Kawamata, Hideo Harigae, MD PhD

Blood (2016) 128 (22): 76.

https://doi.org/10.1182/blood.V128.22.76.76

Published: 2016

Journal Articles

Modeling Bone Marrow Failure and MDS in Shwachman Diamond Syndrome Using Induced Pluripotent Stem Cells

Melisa Ruiz-Gutierrez, MD PhD, Ozge Vargel Bolukbasi, PhD, Linda Vo, Ryohichi Sugimura, MD PhD, Marilyn Sanchez Bonilla, MS, Andriana Kotini, PhD, Carl D. Novina, MD PhD, George Q. Daley, MD PhD, Eirini P. Papapetrou, MD PhD, Akiko Shimamura, MD PhD

Blood (2016) 128 (22): 1496.

https://doi.org/10.1182/blood.V128.22.1496.1496

Published: 2016

Journal Articles

Patient-Derived Induced Pluripotent Stem Cells Identified SLITRK4 As a Causative Gene of Chronic Myelomonocytic Leukemia

Sho Yamazaki, MD, PhD, Kazuki Taoka, MD, PhD, Shunya Arai, MD, PhD, Masashi Miyauchi, MD, PhD, Keisuke Kataoka, MD PhD, Akihide Yoshimi, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2016) 128 (22): 1134.

https://doi.org/10.1182/blood.V128.22.1134.1134

Published: 2016

Journal Articles

Pluripotent Reprogramming of Human AML Resets Leukemic Behavior and Models Therapeutic Targeting of Subclones

Mark Ping Chao, MD PhD, Gentles Andrew, PhD, Chatterjee Susmita, MS, Andreas Reinisch, MDPhD, M. Ryan Corces, PhD, Jinfeng Shen, PhD, Morganti Rachel, Rahul Singha, PhD, Daniel Haag, PhD, Marius Wernig, PhD, Joseph Wu, MD PhD, Ravi Majeti, MD PhD

Blood (2016) 128 (22): 575.

https://doi.org/10.1182/blood.V128.22.575.575

Published: 2016

Journal Articles

Genetic Engineering of Pluripotent Cells for the Continuous Derivation of Off-the-Shelf Effector Lymphocytes with Enhanced Therapeutic Persistence By Overcoming the Host Histocompatibility Barrier

Matthieu Bauer, PhD, Raedun Clarke, PhD, Jeffrey Sasaki, B.S., Brian Groff, B.S., Tom Tong Lee, PhD, Weijie Lan, PhD, Ramzey Abujarour, PhD, Greg Bonello, Michelle Burrascano, Megan Robinson, BS, Ryan Bjordahl, PhD, Svetlana Gaidarova, M.S., Stewart E. Abbot, PhD BSc, MSc, Scott Wolchko, MS, Daniel Shoemaker, PhD, Bahram Valamehr, PhD MBA

Blood (2016) 128 (22): 2165.

https://doi.org/10.1182/blood.V128.22.2165.2165

Published: 2016

Journal Articles

Blast Crisis in a Dish: Generation of a Blast Crisis Model in Chronic Myeloid Leukemia (CML) Using Patient-Specific Induced Pluripotent Stem Cells ( iPSC)

Gladys Telliam, Christophe Desterke, PhD, Olivier Féraud, PhD, Frank Griscelli, PharmD, PhD, Noufissa Oudrhiri, Micheline Fontaine Arnoux, Radhia Najar, PhD, Herve Acloque, PhD, Annelise Bennaceur-Griscelli, MD PhD, Ali G Turhan, MD, PhD

Blood (2016) 128 (22): 933.

https://doi.org/10.1182/blood.V128.22.933.933

Published: 2016

Journal Articles

In Vivo Generation of Engraftable Murine Hematopoietic Stem Cells from Induced Pluripotent Stem Cells through Hemogenic Endothelium

Masao Tsukada, MD, Satoshi Yamazaki, PhD, Yasunori Ota, MD PhD, Hiromitsu Nakauchi, MD PhD

Blood (2016) 128 (22): 3866.

https://doi.org/10.1182/blood.V128.22.3866.3866

Published: 2016

Journal Articles

Single-Cell-State Culture of Human Pluripotent Stem Cells Increases Transfection Efficiency

Takenobu Nii, PhD, Hiroshi Kohara, PhD, Tomotoshi Marumoto, MD PhD, Tetsushi Sakuma, PhD, Takashi Yamamoto, PhD, Kenzaburo Tani, MD PhD

Blood (2015) 126 (23): 2037.

https://doi.org/10.1182/blood.V126.23.2037.2037

Published: 2015

Journal Articles

Developing a Model of Human Pluripotent to Hematopoietic Stem Cell Development in Mistrg Mice

John Astle, MD PhD, Yangfei Xiang, PhD, Anthony Rongvaux, PhD, Carla Weibel, Henchey Elizabeth, Stephanie Halene, MD, PhD, In-Hyun Park, PhD, Richard Flavell, PhD

Blood (2015) 126 (23): 4755.

https://doi.org/10.1182/blood.V126.23.4755.4755

Published: 2015

Journal Articles

Human Induced Pluripotent Stem Cells Incorporating Safe Harbor Loci Integrated Inducible Suicide Systems for Use in the Application of Cellular Therapeutics

Xiaosong Huang, PhD, Weijie Lan, PhD, Philippe Parone, PhD, Raedun Clarke, PhD, Ramzey Abujarour, PhD, Megan Robinson, BS, Miguel Meza, MS, Sarah Raynel, MS, Betsy Rezner, BS, David Robbins, BS, Tom Tong Lee, PhD, Daniel Shoemaker, PhD, Bahram Valamehr, PhD MBA

Blood (2015) 126 (23): 3237.

https://doi.org/10.1182/blood.V126.23.3237.3237

Published: 2015

Journal Articles

KBP-1 Supports Acute Myeloid Leukemia Development

Jingjing Xie, PhD, Zhigang Lu, Chengcheng Zhang, PhD

Blood (2015) 126 (23): 1378.

https://doi.org/10.1182/blood.V126.23.1378.1378

Published: 2015

Journal Articles

Reprogramming of Leukemic and Pre-Leukemic Cells from Primary Human De Novo Acute Myeloid Leukemia Samples into Induced Pluripotent Stem (iPS) Cells

David Spencer, MDPhD, Daniel R. George, Jeffery M. Klco, MDPhD, Timothy J. Ley, MD

Blood (2015) 126 (23): 1862.

https://doi.org/10.1182/blood.V126.23.1862.1862

Published: 2015

NARROW

Generation of Fanconi Anemia iPSC Clones By Addition of a Small Molecule Inhibitor of p53 during Reprogramming

Congenital X-Linked Myelodysplasia with Tetraploidy Is Associated with De Novo Germline C-Terminal Mutation of SEPT6, a Septin Filament Protein

Human Pluripotent Stem Cell-Derived Blood Cells for Therapies

Platelet-Targeted Gene Therapy of Hemophilia a Using Hematopoietic Stem Cells Derived from Genome-Edited Induced Pluripotent Stem Cells

The Activated TGFβ Pathway in Shwachman Diamond Syndrome Impairs Hematopoiesis and Is Down-Regulated By Deletion of 7q

Efficient Ex Vivo Expansion of Human Umbilical Cord Blood-Derived Small CD133 + lin - CD45 - Stem Cells Expressing Pluripotency Markers in Presence of Histone Deacethylase Inhibitors—As a New Challenging Strategy to Obtain Multipotent Cells for Regenerative Medicine

B Cell-Derived Induced Pluripotent Stem Cells Are Useful for Determining the Cellular Origin of Abnormal B Cells in Multiple Myeloma

Ips Technology Revealed the Genetic and Functional Diversity Present in a Secondary AML Patient

Generation of Induced Pluripotent Stem Cell-Derived Erythroblasts from a Patient with X-Linked Sideroblastic Anemia

Modeling Bone Marrow Failure and MDS in Shwachman Diamond Syndrome Using Induced Pluripotent Stem Cells

Patient-Derived Induced Pluripotent Stem Cells Identified SLITRK4 As a Causative Gene of Chronic Myelomonocytic Leukemia

Pluripotent Reprogramming of Human AML Resets Leukemic Behavior and Models Therapeutic Targeting of Subclones

Genetic Engineering of Pluripotent Cells for the Continuous Derivation of Off-the-Shelf Effector Lymphocytes with Enhanced Therapeutic Persistence By Overcoming the Host Histocompatibility Barrier

Blast Crisis in a Dish: Generation of a Blast Crisis Model in Chronic Myeloid Leukemia (CML) Using Patient-Specific Induced Pluripotent Stem Cells ( iPSC)

In Vivo Generation of Engraftable Murine Hematopoietic Stem Cells from Induced Pluripotent Stem Cells through Hemogenic Endothelium

Single-Cell-State Culture of Human Pluripotent Stem Cells Increases Transfection Efficiency

Developing a Model of Human Pluripotent to Hematopoietic Stem Cell Development in Mistrg Mice

Human Induced Pluripotent Stem Cells Incorporating Safe Harbor Loci Integrated Inducible Suicide Systems for Use in the Application of Cellular Therapeutics

KBP-1 Supports Acute Myeloid Leukemia Development

Reprogramming of Leukemic and Pre-Leukemic Cells from Primary Human De Novo Acute Myeloid Leukemia Samples into Induced Pluripotent Stem (iPS) Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only